Correlation Between Novo Nordisk and Per Aarsleff

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Per Aarsleff at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Per Aarsleff into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Per Aarsleff Holding, you can compare the effects of market volatilities on Novo Nordisk and Per Aarsleff and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Per Aarsleff. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Per Aarsleff.

Diversification Opportunities for Novo Nordisk and Per Aarsleff

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Novo and Per is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Per Aarsleff Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Per Aarsleff Holding and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Per Aarsleff. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Per Aarsleff Holding has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Per Aarsleff go up and down completely randomly.

Pair Corralation between Novo Nordisk and Per Aarsleff

Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the Per Aarsleff. In addition to that, Novo Nordisk is 1.27 times more volatile than Per Aarsleff Holding. It trades about 0.0 of its total potential returns per unit of risk. Per Aarsleff Holding is currently generating about 0.33 per unit of volatility. If you would invest  40,450  in Per Aarsleff Holding on September 1, 2024 and sell it today you would earn a total of  5,650  from holding Per Aarsleff Holding or generate 13.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Novo Nordisk AS  vs.  Per Aarsleff Holding

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Per Aarsleff Holding 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Per Aarsleff Holding are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Per Aarsleff sustained solid returns over the last few months and may actually be approaching a breakup point.

Novo Nordisk and Per Aarsleff Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and Per Aarsleff

The main advantage of trading using opposite Novo Nordisk and Per Aarsleff positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Per Aarsleff can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Per Aarsleff will offset losses from the drop in Per Aarsleff's long position.
The idea behind Novo Nordisk AS and Per Aarsleff Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Managers
Screen money managers from public funds and ETFs managed around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins